Literature DB >> 8107349

[Henoch-Schönlein purpura associated with pulmonary tuberculosis].

Y Mishima1, M Takeuchi, K Kamisaka, C Okada, A Tada, S Kawahara, R Soda, K Takahashi, M Kibata.   

Abstract

A 34-year-old man was admitted to our hospital because of cough and fever. Chest radiograph showed multiple cavities mainly on the right lung. His sputum was positive for acid-fast bacilli on smear, and he was treated with daily isoniazide, rifampicin and streptomycin. Antituberculous treatment was successfully performed, so acid-fast bacilli of his sputa disappeared on smear and culture. Five months later, he developed a purpuric lesions over both legs accompanied by low grade fever and arthralgia, but proteinuria and abdominal pain could not be observed. Laboratory findings showed a normal platelet count and a normal bleeding time. High levels of serum IgG, IgA, C3 and C4 were evident. ASLO and ASK titer were elevated and they markedly increased within two weeks. A direct invasion of the vessel wall by tubercle bacilli is deniable because antituberculous treatment was successfully continued. Henoch-Schönlein purpura was diagnosed judging from these findings. High levels of ASLO and ASK suggest a preceding streptococcal infection for developing purpura but a possible infectious focus could not be identified. He was treated with 15 mg of prednisolone daily for two weeks and the lesion was subsided. The effect of prednisolone suggests that a subsequent antigen-antibody interaction caused by a streptococcal infection may participate in the formation of the purpura.

Entities:  

Mesh:

Year:  1994        PMID: 8107349

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  2 in total

1.  A Rare Case of Henoch-Schönlein Purpura and Mycobacterium xenopi Pulmonary Infection.

Authors:  Jad Saliba; Maximilien Grall; Christian Saliba
Journal:  Cureus       Date:  2021-02-24

Review 2.  Pulmonary tuberculosis presenting as henoch-schönlein purpura: Case report and literature review.

Authors:  Jie Li; Xiao-Zi Wang; Rui-Cang Wang; Jie Yang; Hong-Ling Hao; Li-Ying Xue
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.